Background: Overweight and obesity are rising in developing countries among all age groups. Children and adolescents are, therefore, exposed to higher risk of developing hypertension. Early identification can help avoiding or lessening complications through the life span. In order to plan adequate prevention programs, cities need to identify the prevalence of such condition. We aimed to identify the prevalence of Elevated Arterial Pressure (EAP) and associated factors in students from the municipality of Cajazeiras-PB, Brazil, a region in the Northeast of Brazil.
Methods and Findings:At this cross-sectional study, in 2011, we measured arterial pressure of 690 children and adolescents from both genders, age 10 to 15-year-old, following the parameters recommended by the Fourth Report on the Diagnosis, Evaluation and Treatment of High Blood Pressure in Children and Adolescents. We measured sociodemographic, behavioral, clinical, and hemodynamic variables. In the statistical analysis, we used the software Stata/IC 12.1. The significance level was established as p≤.05. In our total sample 55.4% were female, and the mean age was 12.8 years (SD: 1.4). Prevalence of EAP was 3.5% and it was associated with large waist circumference, overweight, experience of hunger, and tobacco exposure. The prevalence of systolic and diastolic hypertension were 2.5% and 1.7%, respectively. In a logistic regression we observed that subjects exposed to tobacco were 2.65 times more likely to have EAP (95% CI: 1.021-6.861), when compared to their not exposed peers. Those that ever experienced hunger had an odds ratio of 3.73 to present EAP (95%
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.